OpenURL Connection Search

Select item for more details and to access through your institution.

The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis?
Published in:
1990
By:
- Abshire, Thomas C.;
- Gold, Stuart H.;
- Odom, Lorrie F.;
- Carson, Steven D.;
- Hathaway, William E.;
- Abshire, T C;
- Gold, S H;
- Odom, L F;
- Carson, S D;
- Hathaway, W E
Publication type:
journal article
Bleeding‐related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.
Published in:
Haemophilia, 2018, v. 24, n. 4, p. 628, doi. 10.1111/hae.13473
By:
- Holm, E.;
- Carlsson, K. Steen;
- Lövdahl, S.;
- Lail, A. E.;
- Abshire, T. C.;
- Berntorp, E.
Publication type:
Article
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.
Published in:
Haemophilia, 2017, v. 23, n. 2, p. 207, doi. 10.1111/hae.13081
By:
- Kulkarni, R.;
- Presley, R. J.;
- Lusher, J. M.;
- Shapiro, A. D.;
- Gill, J. C.;
- Manco‐Johnson, M.;
- Koerper, M. A.;
- Abshire, T. C.;
- DiMichele, D.;
- Hoots, W. K.;
- Mathew, P.;
- Nugent, D. J.;
- Geraghty, S.;
- Evatt, B. L.;
- Soucie, J. M.
Publication type:
Article
Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).
Published in:
Haemophilia, 2013, v. 19, n. 1, p. 76, doi. 10.1111/j.1365-2516.2012.02916.x
By:
- Abshire, T. C.;
- Federici, A. B.;
- Alvárez, M. T.;
- Bowen, J.;
- Carcao, M. D.;
- Cox Gill, J.;
- Key, N. S.;
- Kouides, P. A.;
- Kurnik, K.;
- Lail, A. E.;
- Leebeek, F. W. G.;
- Makris, M.;
- Mannucci, P. M.;
- Winikoff, R.;
- Berntorp, E.
Publication type:
Article
Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.
Published in:
Haemophilia, 2012, v. 18, n. 5, p. 798, doi. 10.1111/j.1365-2516.2012.02789.x
By:
- KEMPTON, C. L.;
- ABSHIRE, T. C.;
- DEVERAS, R. A.;
- HOOTS, W. K.;
- GILL, J. C.;
- KESSLER, C. M.;
- KEY, N. S.;
- KONKLE, B. A.;
- KURIAKOSE, P.;
- MACFARLANE, D. E.;
- BERGMAN, G.
Publication type:
Article
Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII.
Published in:
Haemophilia, 2011, v. 17, n. 1, p. 155, doi. 10.1111/j.1365-2516.2010.02345.x
By:
- KEMPTON, C. L.;
- MEEKS, S. L.;
- DONALD HARVEY, R.;
- ABSHIRE, T. C.
Publication type:
Article
Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.
Published in:
Haemophilia, 2008, v. 14, n. 6, p. 1159, doi. 10.1111/j.1365-2516.2008.01832.x
By:
- MEEKS, S. L.;
- ABSHIRE, T. C.
Publication type:
Article

Found: 7

The coagulopathy of childhood leukemia. Thrombin activation or primary fibrinolysis?

Bleeding‐related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network.

Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System.

Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).

Pharmacokinetics and safety of OBI-1, a recombinant B domain-deleted porcine factor VIII, in subjects with haemophilia A.

Evaluation of factor VIII pharmacokinetics and anti-factor VIII antibodies in four boys with haemophilia A and a poor clinical response to factor VIII.

Abnormalities of prothrombin: a review of the pathophysiology, diagnosis, and treatment.